Results 221 to 230 of about 715,584 (321)

Studies on Serum Alkaline Phosphatase Activities and Isoenzymes in Patients with Hepatocellular Carcinoma.

, 1977
J Nawata, Hideo Nishimura, Mikio Hayakawa, Mitsuru Odawara, Tadayoshi Takemoto   +4 more
openalex   +2 more sources

Hepatocellular carcinoma arising in noncirrhotic and highly cirrhotic livers: A comparative study of histopathology and frequency of hepatitis B markers [PDF]

, 1982
Kunio Okuda, Toshiro Nakashima, Kazuyoshi Sakamoto, T. Ikari, Hisamitsu Hidaka, Yasuhiko Kubo, Koshi Sakuma, Yoji Motoike, Hiroaki Okuda, Hiroshi Obata   +9 more
openalex   +1 more source

Integrated Metabolic and Inflammatory Clustering Reveals Distinct Risk Profiles for Digestive Diseases

Advanced Science, EarlyView.
This study analyzes 398 432 participants, identifying four distinct metabolic‐inflammatory subtypes. These subtypes show a significant association with digestive disease risk. Cluster‐associated metabolite signatures partially explain this link. Machine learning models using these metabolites accurately predict risk for ten digestive diseases. Key risk
Zhenhe Jin, Qichen Chen, Liangfeng Zhou, Kexin Ye, Zhaoxue Liu, Wenxi Jiang, Linwen Luo, Yize Wang, Xiaohua Ye, Chaohui Yu, Zhe Shen   +10 more
wiley   +1 more source

Recent Advances in Ablative Therapies for Hepatocellular Carcinoma. [PDF]

Cancers (Basel)
Abu Zahra S, Nadeem A, Kundu A, Gibson N, Haggaz A, Sato KT, Lewandowski RJ, Gordon AC.   +7 more
europepmc   +1 more source

A study of clinicohistological changes in hepatocellular carcinoma with chemotherapy

, 1979
Naofumi Eriguchi
openalex   +2 more sources

Biologic significance of the detection of HBsAg and HBcAg in liver and tumor from 204 HBsAg-positive patients with primary hepatocellular carcinoma [PDF]

, 1989
Hey‐Chi Hsu, Tsung‐Teh Wu, Jin‐Chuan Sheu, Chieng-Yen Wu, Tzyy‐Jen Chiou, Chu-Shue Lee, Ding‐Shinn Chen   +6 more
openalex   +1 more source

Lactate‐Modulating Nanoreactors Facilitate Self‐Amplifying Pyroptosis and the cGAS‐STING Cascade for Potentiated Catalytic‐Immunotherapy

Advanced Science, EarlyView.
An intelligent lactate‐depleting LOCoF2 (CoF2@LOx) nanoreactor system is developed to effectively induce self‐reinforced pyroptosis and activate the cGAS‐STING signaling pathway, thereby inducing a strong immune response and enhancing the therapeutic effectiveness of catalytic immunotherapy.
Linzhu Zhang, Shumin Sun, Duo Wang, Nailin Yang, Di Wang, Jihu Nie, Zifan Pei, Juan Qin, Lei Zhang, Haidong Zhu, Liang Cheng   +10 more
wiley   +1 more source

Production of abnormal prothrombin (PIVKA-II) by hepatocellular carcinoma. A clinical and experimental study.

, 1986
Hiroaki Okuda, Toshimi Nakanishi, Ryuji FURUKAWA, Etsuko Hashimoto, Hiroshi Obata   +4 more
openalex   +2 more sources

NQO1/p65/CXCL12 Axis‐Recruited Tregs Mediate Resistance to Anti‐PD‐1 Plus Lenvatinib Therapy in PIVKA‐II‐Positive Hepatocellular Carcinoma

Advanced Science, EarlyView.
High PIVKA‐II expression in HCC correlates with resistance to anti‐PD‐1 plus lenvatinib, driven by an immunosuppressive TME. NQO1/p65/CXCL12 axis recruits Tregs to promote resistance to anti‐PD‐1 plus lenvatinib in HCC with high PIVKA‐II expression.
Biao Gao, Yafei Wang, Zhuoya Sun, Haowen Tang, Yinbiao Cao, Hao Jiang, Wenwen Zhang, Yinzhe Xu, Bingyang Hu, Zhe Liu, Guankun Mao, Xuerui Li, Junfeng Li, Tao Wan, Bing Liu, Xiao Zhao, Shunchang Jiao, Chonghui Li, Shichun Lu   +18 more
wiley   +1 more source

Hepatocellular Carcinoma: A Comprehensive Review. [PDF]

Diseases
Amin N, Anwar J, Sulaiman A, Naumova NN, Anwar N.   +4 more
europepmc   +1 more source